Sorry, you need to enable JavaScript to visit this website.

A Study of Different Doses of Vupanorsen in Participants Who Have an Abnormal Level of Lipids (or Fats) in the Blood and Who Are Being Treated With a Class of Medicine Called Statins

A Study of Different Doses of Vupanorsen in Participants Who Have an Abnormal Level of Lipids (or Fats) in the Blood and Who Are Being Treated With a Class of Medicine Called Statins. A Phase 2B Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Dose-Ranging Study to Assess the Efficacy, Safety, and Tolerability of Vupanorsen (PF-07285557) in Statin-Treated Participants With Dyslipidemia.

Category & Conditions: Cardiovasular Diseases and Conditions
Medicine: vupanorsen (PF-07285557)
ClinicalTrials.gov Identifier (NCT): NCT04516291
Protocol ID: C4491011
    Share
PrintDownload
Open Plain Language Summary Result: Click here